Clarity needed on taxation of COVID test costs, says ICAEW

15 Feb 2021

The Institute of Chartered Accountants in England and Wales (ICAEW) has urged HMRC to confirm whether coronavirus (COVID-19) antigen tests paid for by employers will continue to be exempt from income tax and national insurance after 5 April 2021.

Guidance published by HMRC states that employers and employees will not be liable for any income tax or national insurance contributions (NICs) on the costs of the test. However, no end date is given for this exemption.

Regulations outlined by HMRC in December confirmed that tests provided by employers would be exempt from 8 December 2020 until 5 April 2021. Additionally, a government announcement confirmed that legislation would be introduced to give a temporary NIC and income tax exemption from 25 January 2021 until 5 April 2021.

The ICAEW has asked HMRC whether new legislation will be created to extend the exemption or whether HMRC intends to use its collection and management powers. The Institute also called for HMRC to provide clarity on the difference between antigen tests and antibody tests, which are not exempt.

Copyright

© 2021 Volans, Leach & Schofield. All rights reserved.

We use cookies on this website, you can find more information about cookies here.
Contact Us

Please call:
0113 245 7031

Quick links

Home | Contact us | Credit | Site map | Accessibility | Disclaimer | Help |


Registered to carry out audit work by the Institute of Chartered Accountants in England and Wales. Authorised and regulated by the FCA.

Our FCA Register number is 542783 which can be checked at www.fca.org.uk/register. The Financial Conduct Authority does not regulate taxation and trust advice, personal finance and some aspects of commercial property investment.

Volans, Leach & Schofield is a trading style of Volans Limited - Company number 07549089.

Registered in England and Wales with registered office at Volans, Leach & Schofield, 10 Blenheim Terrace, Woodhouse Lane, Leeds, West Yorkshire LS2 9HX .

Directors: Christopher Smart FCA CTA and Martin Knaggs FCCA.

Please check the information in the Disclaimer page before proceeding.